针对CD4+T细胞葡萄糖代谢:一种针对1型糖尿病的新型免疫治疗方法
Ying Niu1,2,3, Na Wang2, Leiying Qiao4
1Department of Endocrinology, The First Hospital of Lanzhou University, Lanzhou 730000, China.
Biomolecules
|June 26, 2025
概括
1型糖尿病 (T1D) 涉及由葡萄糖代谢调节的CD4+T细胞. 针对这些代谢途径为T1D治疗和免疫反应控制提供了新的策略.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
- 1型糖尿病 (T1D) 是一种糖尿病.
背景情况:
- 1型糖尿病 (T1D) 是一种针对胰岛素产生β细胞的自身免疫性疾病.
- CD4+ T 细胞子集是T1D 病原发生的关键驱动因素.
- 葡萄糖代谢途径极大地影响了CD4+ T细胞的功能.
研究的目的:
- 审查葡萄糖代谢如何影响CD4+T细胞分化和T1D中的功能.
- 要总结针对T1D免疫控制的葡萄糖代谢的干预措施.
主要方法:
- 对T1D中葡萄糖代谢和T细胞功能研究的文献综述.
- 在糖解和OXPHOS中分析关键酶和中间体.
- 通过代谢途径检查T细胞分化和功能调节.
主要成果:
- 葡萄糖代谢途径,包括糖解和OXPHOS,显著调节CD4+T细胞的激活,增殖和分化.
- 代谢干预措施在控制T细胞介导的T1D免疫反应方面表现有前途.
结论:
- 了解CD4+T细胞中的葡萄糖代谢对于T1D病变的产生至关重要.
- 代谢途径调节为T1D治疗提供了潜在的治疗途径.
相关概念视频
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes: Management and Pharmacotherapy
410
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
410
Carbohydrate Metabolism
11.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.8K
Tumor Immunotherapy
675
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Oral Hypoglycemic Agents: Biguanides and Glitazones
310
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
310


